EMEA-002360-PIP01-18-M02

Key facts

Active substance
Tirzepatide
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0174/2022
PIP number
EMEA-002360-PIP01-18-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Eli Lilly and Company Ltd

Email: EU_PAEDIATRIC@LILLY.COM    
Tel. +44 1256315000

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
4 ratings